N-Acetyl Varenicline

N-Acetyl Varenicline Struktur
1213781-59-9
CAS-Nr.
1213781-59-9
Englisch Name:
N-Acetyl Varenicline
Synonyma:
Varenicline N-Acetyl;Varnicline acetyl Impurity;1-(6,7,9,10-Tetrahydro-6,10-methano-8H-pyrazino[2,3-h][3]benzazepin-8-yl)ethanone;Ethanone, 1-(6,7,9,10-tetrahydro-6,10-methano-8H-pyrazino[2,3-h][3]benzazepin-8-yl)-
CBNumber:
CB34803857
Summenformel:
C15H15N3O
Molgewicht:
253.3
MOL-Datei:
1213781-59-9.mol

N-Acetyl Varenicline Eigenschaften

Siedepunkt:
481.2±45.0 °C(Predicted)
Dichte
1.294±0.06 g/cm3(Predicted)
Löslichkeit
Chloroform (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
1.56±0.20(Predicted)
Farbe
Light Orange to Orange

Sicherheit

N-Acetyl Varenicline Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

1-(6,7,9,10-Tetrahydro-6,10-methano-8H-pyrazino[2,3-h][3]benzazepin-8-yl)ethanone is related to its parent compound N-Formyl Varenicline (F701650), which is a metabolite of Varenicline and metabolite M5. Also, it is derived from Varenicline Tartrate (V098490), which is a nicotinic α4β2 acetylcholine receptor partial agonist and used to aid in smoking cessation (1,2,3,4).

N-Acetyl Varenicline Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


N-Acetyl Varenicline Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shenzhen ruikai de biotechnology co., ltd. 0755-61348847 17820674378
2682116078@qq.com China 7844 58
Hubei Ruinuo Pharmaceutical Technology Co., Ltd 13165688766
3008058303@qq.com China 5000 58
guoyungurui 18162595016
3287908757@qq.com China 9981 58
Baoji Didu Pharmaceutical and Chemical Co., Ltd 029-81148929 13186179623
1049@dideu.com China 10011 58

  • Varenicline N-Acetyl
  • Ethanone, 1-(6,7,9,10-tetrahydro-6,10-methano-8H-pyrazino[2,3-h][3]benzazepin-8-yl)-
  • 1-(6,7,9,10-Tetrahydro-6,10-methano-8H-pyrazino[2,3-h][3]benzazepin-8-yl)ethanone
  • Varnicline acetyl Impurity
  • 1213781-59-9
Copyright 2019 © ChemicalBook. All rights reserved